Evaluation of the diagnostic value of the Modified Evan’s Blue Dye Test for assessing aspiration in tracheostomized critically ill patients: A systematic review and meta-analysis

Keyword: Dysphagia

Publisher: Plos.org

Published: May 13, 2026

Abstract Dysphagia and aspiration are common complications in tracheostomized critically ill patients. The Modified Evans Blue Dye Test (MEBDT) is a non-invasive, bedside, adjunctive rule-in signal … [+25913 chars]

Read Full Story ↗

Related Content

Related Story Meeting the Aged Care Quality Standards – Food and nutrition

Npagroup.com.au
Related Story CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research

PRNewswire
Related Story Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer

Associated Press